Evidence boundaries and integrated disease management of microbial disease risks in protected Cymbidium faberi production: a translational framework and validation agenda
- 1College of Urban Construction, Luoyang Polytechnic
- 2Agricultural Resources Research Center, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences
- 3College of Agriculture, Henan University of Science and Technology
Abstract
Cymbidium faberi ( C. faberi ) is an economically and culturally important orchid in East Asia, yet direct species-specific evidence for microbial diseases under protected cultivation remains limited. This critical narrative review synthesizes evidence on orchid diseases, protected-crop disease ecology, plant pathogen detection and diagnosis, biological control, and plant microbiome interactions. Direct C. faberi studies comprise one localized anthracnose-oriented report, baseline studies of root- and rhizosphere-associated microorganisms, and candidate antagonistic endophytes. However, they do not establish a contemporary pathogen inventory, species-resolved epidemiology, disease-associated microbiome dynamics, or validated management efficacy. Evidence from related Cymbidium species, other orchids, protected crops, and general plant-pathology systems is therefore interpreted according to host proximity, pathogen biology, production environment, and management relevance. Within this synthesis, disease risk is organized provisionally in a disease-complex framework in which environmental filtering, pathogen pressure, host status, and microbiome resilience are considered jointly; the framework does not assume that stable multi-pathogen synergistic pathogenesis has been demonstrated. A node-based translational Integrated Disease Management framework links mother-plant accession, clonal propagation, potting, vegetative growth, flowering, abnormal-batch disposition, and release decisions. The principal research gaps are pathogen isolation and causal confirmation, species-resolved pathogen surveillance, quantitative microclimate and inoculum thresholds, microbiome-function testing, and prospective validation of diagnostic and prediction tools. The framework is intended as a provisional decision-support and research-prioritization structure rather than a validated C. faberi -specific management standard.
Related
- Comparative Veterinary Psychopharmacology in Dogs and Cats: Neurotransmitter Targets, Translational Boundaries, and Species-Specific Pharmacokinetics.
- Computational Prediction of Recombinant Expression Efficiency for Industrial Enzymes: An Integrated Co-Translational Sequence Analysis Platform
- Translational neuroscience in psychoeducation: Mapping nonmotor circuitry to clinical management in movement disorders
- Interface Habitats: An Integrated Observing Strategy for Earth’s Most Dynamic and Consequential Aquatic Boundaries
- Physiological Determinants of High Nitrogen-Use Efficiency in Waxy Sorghum: Integrated Analysis of Biomass Production, Nitrogen Assimilation, and Antioxidant Metabolism
BibTeX
@article{deng2026evidence,
title = {{Evidence boundaries and integrated disease management of microbial disease risks in protected Cymbidium faberi production: a translational framework and validation agenda}},
author = {Yufeng Deng and Dongfeng Wei and Shichao Gu and Min Yu and Jinzhi Yao and Meicheng Zhao and Lei Qin and Taiji Kou},
journal = {Frontiers in Plant Science},
year = {2026},
month = oct,
doi = {10.3389/fpls.2026.1952084},
url = {https://www.frontiersin.org/articles/10.3389/fpls.2026.1952084/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Evidence boundaries and integrated disease management of microbial disease risks in protected Cymbidium faberi production: a translational framework and validation agenda
AU - Yufeng Deng
AU - Dongfeng Wei
AU - Shichao Gu
AU - Min Yu
AU - Jinzhi Yao
AU - Meicheng Zhao
AU - Lei Qin
AU - Taiji Kou
PY - 2026
DA - 2026/10/09
JO - Frontiers in Plant Science
DO - 10.3389/fpls.2026.1952084
UR - https://www.frontiersin.org/articles/10.3389/fpls.2026.1952084/full
AB - Cymbidium faberi ( C. faberi ) is an economically and culturally important orchid in East Asia, yet direct species-specific evidence for microbial diseases under protected cultivation remains limited. This critical narrative review synthesizes evidence on orchid diseases, protected-crop disease ecology, plant pathogen detection and diagnosis, biological control, and plant microbiome interactions. Direct C. faberi studies comprise one localized anthracnose-oriented report, baseline studies of root- and rhizosphere-associated microorganisms, and candidate antagonistic endophytes. However, they do not establish a contemporary pathogen inventory, species-resolved epidemiology, disease-associated microbiome dynamics, or validated management efficacy. Evidence from related Cymbidium species, other orchids, protected crops, and general plant-pathology systems is therefore interpreted according to host proximity, pathogen biology, production environment, and management relevance. Within this synthesis, disease risk is organized provisionally in a disease-complex framework in which environmental filtering, pathogen pressure, host status, and microbiome resilience are considered jointly; the framework does not assume that stable multi-pathogen synergistic pathogenesis has been demonstrated. A node-based translational Integrated Disease Management framework links mother-plant accession, clonal propagation, potting, vegetative growth, flowering, abnormal-batch disposition, and release decisions. The principal research gaps are pathogen isolation and causal confirmation, species-resolved pathogen surveillance, quantitative microclimate and inoculum thresholds, microbiome-function testing, and prospective validation of diagnostic and prediction tools. The framework is intended as a provisional decision-support and research-prioritization structure rather than a validated C. faberi -specific management standard.
SN - 1664-462X
ER -